Immune-Mediated Destructive Joint Inflammation in Cats (Erosive Immune-Mediated Polyarthritis)

Content

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Erosive immune-mediated polyarthritis in cats is an autoimmune disease characterized by Inflammatory conditions and degradation of the articular cartilage, leading to Pain and limited mobility.

The most important facts at a glance

Erosive immune-mediated polyarthritis (EIPA) in cats is an autoimmune disease where the immune system mistakenly attacks the body’s own joint structures, leading to the destruction of the protective cartilage. This can result in permanent joint damage and deformities. The exact causes are not fully understood, but genetic factors and environmental factors play a role. Viral infections and stress can also affect the immune system and trigger the disease. The most common symptoms include Lameness, a stiff gait, and Joint pain. EIPA is diagnosed through clinical examinations, X-rays, and laboratory analyses. Treatment aims to relieve Inflammatory conditions and Pain and slow down cartilage destruction. This is often done through medications such as NSAID (non-steroidal anti-inflammatory drug) and immunosuppressants. Physiotherapy and an adapted diet can also be helpful. The prognosis depends on the severity of the disease and the response to therapy. Early diagnosis and treatment can significantly improve the quality of life for cats. Preventive measures include a balanced diet, regular veterinary check-ups, and stress reduction. It is important to recognize changes in the cat’s behavior early and seek veterinary advice to prevent or slow the progression of the disease.

Causes

Erosive immune-mediated polyarthritis (EIPA) is one of the autoimmune diseases in which the immune system mistakenly attacks the body’s own cells. In cats, this primarily affects the joint structures, where the cartilage protecting the joint surfaces is destroyed. This destruction leads to erosion of the cartilage and can eventually result in permanent damage and joint deformity.

The exact mechanisms leading to EIPA are not yet fully understood, but it is believed that a genetic predisposition along with environmental factors play a role. Immune complexes that deposit in the joints appear to trigger an inflammatory reaction, leading to the release of enzymes that break down the cartilage.

Possible causes also include viral infections and stress, which can impair the cat’s immune system and trigger an autoimmune reaction. Certain breeds might be genetically more susceptible to developing this disease.

Symptoms

Cats with erosive immune-mediated polyarthritis often show symptoms indicating Pain and Inflammatory conditions in the joints. The most common signs include Stiffness and Lameness, which usually become more apparent after periods of rest. Affected cats might have difficulty getting up or jumping.

Additionally, Swelling and warmth can occur in the affected joints. Cats tend to reduce their movement, which can lead to a general decrease in activity. In some cases, Fever and reduced food intake may occur, indicating a systemic inflammatory reaction.

Chronic pain can also change the cat’s behavior, which may manifest as Irritability or aggression. Changes in gait, such as a limping or stiff walk, are also frequently observed.

Diagnosis

The diagnosis of erosive immune-mediated polyarthritis is based on a combination of clinical findings, imaging procedures, and laboratory tests. The veterinarian will first perform a thorough physical examination and check the joints for Swelling, pain reactions, and restricted movement.

X-rays of the affected joints can help visualize erosive changes and the loss of joint cartilage. In some cases, an ultrasound examination can provide additional information about the condition of the soft tissues in the joint area.

To confirm the diagnosis, blood tests can be performed to check for inflammatory markers and antibodies against the body’s own tissues. A joint fluid analysis can also be performed to identify inflammatory cells and other abnormalities.

Therapy

The treatment of EIPA aims to reduce inflammation, relieve pain, and slow down the destruction of joint cartilage. NSAID (non-steroidal anti-inflammatory drug) medications are frequently used to control inflammation and the associated pain.

Immunosuppressive drugs such as corticosteroids or other specific immunomodulators may be necessary to suppress the autoimmune reaction. These medications usually need to be administered long-term and require regular monitoring by a veterinarian to minimize side effects.

In addition to medical treatment, physiotherapy care can be helpful to improve mobility and prevent muscle atrophy. An adapted diet and weight control are also important to minimize the load on the joints.

Prognosis and follow-up care

The prognosis for cats with erosive immune-mediated polyarthritis depends on the severity of the disease and the response to treatment. With an early diagnosis and appropriate therapy, many cats can maintain a good quality of life and largely preserve their mobility.

However, the disease can progress in some cats and lead to permanent Joint pain and damage. In such cases, the cat’s quality of life can be significantly impaired, and additional measures may be required to relieve pain and improve quality of life.

Regular veterinary check-ups are crucial to monitor the course of the disease and adjust the therapy accordingly. Close cooperation with the veterinarian is vital for the management of this chronic condition.

Prevention

To minimize the risk of developing erosive immune-mediated polyarthritis in cats, it is important to ensure a balanced diet. Good nutrition strengthens the immune system and promotes the cat’s overall health. Make sure the food consists of high-quality proteins, fats, and essential nutrients.

Regular veterinary examinations are also crucial. Through these preventive check-ups, health problems can be detected and treated early before they worsen. Ensure your cat receives all recommended vaccinations to support its immune system.

Stress reduction is another important aspect of prevention. A stress-free environment helps support the immune system and promote the cat’s well-being. Provide plenty of hiding spots and a quiet environment.

Avoid Contact between your cat and other animals that could transmit diseases. Keep your cat indoors or in a secure outdoor area to reduce the risk of infections that could strain the immune system.

Finally, it is important to watch for changes in your cat’s behavior or health and consult a veterinarian immediately if you notice anything unusual. Early intervention can help prevent or slow the progression of the disease.

Frequently asked questions (FAQs)

1. What is erosive immune-mediated polyarthritis in cats?
Erosive immune-mediated polyarthritis (EIMPA) is an autoimmune disease in which the immune system attacks and destroys cartilage and bone in joints, resembling rheumatoid arthritis in humans.
2. What symptoms do affected cats show?
Stiffness, lameness, swollen and tender joints, reduced activity, fever and, in advanced stages, visible joint deformity.
3. How is the diagnosis established?
Joint tap and synovial fluid analysis (elevated cell count), radiographs showing erosive joint changes, blood tests and exclusion of infectious causes.
4. What are the causes?
The exact cause is unknown. Genetic predisposition, viral triggers (FIV, FeLV, calicivirus) and immune dysregulation are considered contributing factors.
5. How is it treated?
Immunosuppressants (prednisolone, chlorambucil, ciclosporin), NSAIDs for pain relief and physiotherapy. Treatment is usually lifelong.
6. Can it be cured?
Complete cure is rare. The aim is remission and freedom from pain. Some cats can be brought into remission with appropriate immunosuppression.
7. Which joints are most commonly affected?
All joints can be involved, with carpal, tarsal, shoulder and hip joints most frequently affected. The distribution is usually symmetrical.
8. How does it differ from osteoarthritis?
Osteoarthritis is degenerative, caused by wear, and lacks an immune component. EIMPA is immune-mediated with inflammatory erosive joint destruction and systemic inflammatory signs.
9. Which medications are used?
Prednisolone is the primary immunosuppressant. Chlorambucil or ciclosporin is added when response is inadequate. NSAIDs provide supplementary analgesia.
10. What is the prognosis?
Prognosis is guarded. Some cats respond well to treatment; others show progressive joint destruction despite therapy.